These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 23407349)

  • 41. Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy.
    Hoffmann MM; Scharnagl H; Panagiotou E; Banghard WT; Wieland H; März W
    J Am Soc Nephrol; 2001 Mar; 12(3):524-530. PubMed ID: 11181800
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Haplotype analysis suggest common founders in carriers of the recurrent BRCA2 mutation, 3398delAAAAG, in French Canadian hereditary breast and/ovarian cancer families.
    Oros KK; Leblanc G; Arcand SL; Shen Z; Perret C; Mes-Masson AM; Foulkes WD; Ghadirian P; Provencher D; Tonin PN
    BMC Med Genet; 2006 Mar; 7():23. PubMed ID: 16539696
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lipoprotein glomerulopathy associated with psoriasis vulgaris: report of 2 cases with apolipoprotein E3/3.
    Chang CF; Lin CC; Chen JY; Yang AH; Shiao MS; Kao JT; Yang WC
    Am J Kidney Dis; 2003 Sep; 42(3):E18-23. PubMed ID: 12955707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparative study of apolipoprotein-E polymorphism and plasma lipid levels in dyslipidemic and asymptomatic subjects, and their implication in cardio/cerebro-vascular disorders.
    Ferreira CN; Carvalho MG; Fernandes AP; Lima LM; Loures-Valle AA; Dantas J; Janka Z; Palotás A; Sousa MO
    Neurochem Int; 2010 Jan; 56(1):177-82. PubMed ID: 19819279
    [TBL] [Abstract][Full Text] [Related]  

  • 45. SNPs and interaction analyses of myocilin, optineurin, and apolipoprotein E in primary open angle glaucoma patients.
    Fan BJ; Wang DY; Fan DS; Tam PO; Lam DS; Tham CC; Lam CY; Lau TC; Pang CP
    Mol Vis; 2005 Aug; 11():625-31. PubMed ID: 16148883
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy.
    Li W; Wang Y; Han Z; Luo C; Zhang C; Xiong J
    Kidney Blood Press Res; 2014; 39(4):330-9. PubMed ID: 25300642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Discovery of a Chinese Tibetan patient with lipoprotein glomerulopathy due to APOE Osaka/Kurashiki variant].
    Yang Z; Wu H; Hu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Feb; 37(2):166-169. PubMed ID: 32034747
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.
    Tokura T; Itano S; Kobayashi S; Kuwabara A; Fujimoto S; Horike H; Satoh M; Komai N; Tomita N; Matsunaga A; Saito T; Sasaki T; Kashihara N
    J Atheroscler Thromb; 2011; 18(6):536-41. PubMed ID: 21467726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Haplotype analysis of two recurrent genomic rearrangements in the BRCA1 gene suggests they are founder mutations for the Greek population.
    Pertesi M; Konstantopoulou I; Yannoukakos D
    Clin Genet; 2011 Oct; 80(4):375-82. PubMed ID: 20840220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Founder mutations account for the majority of BRCA1-attributable hereditary breast/ovarian cancer cases in a population from Tuscany, Central Italy.
    Papi L; Putignano AL; Congregati C; Zanna I; Sera F; Morrone D; Falchetti M; Turco MR; Ottini L; Palli D; Genuardi M
    Breast Cancer Res Treat; 2009 Oct; 117(3):497-504. PubMed ID: 18821011
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD.
    van der Zee J; Rademakers R; Engelborghs S; Gijselinck I; Bogaerts V; Vandenberghe R; Santens P; Caekebeke J; De Pooter T; Peeters K; Lübke U; Van den Broeck M; Martin JJ; Cruts M; De Deyn PP; Van Broeckhoven C; Dermaut B
    Brain; 2006 Apr; 129(Pt 4):841-52. PubMed ID: 16495329
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of new founder Alu-mediated rearrangements in MSH2 gene associated with a Lynch syndrome phenotype.
    Pérez-Cabornero L; Borrás Flores E; Infante Sanz M; Velasco Sampedro E; Acedo Becares A; Lastra Aras E; Cuevas González J; Pineda Riu M; Ramón y Cajal Asensio T; Capellá Munar G; Miner Pino C; Durán Domínguez M
    Cancer Prev Res (Phila); 2011 Oct; 4(10):1546-55. PubMed ID: 21778331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel glomerular lipoprotein deposits associated with apolipoprotein E2 homozygosity.
    Sakatsume M; Kadomura M; Sakata I; Imai N; Kondo D; Osawa Y; Shimada H; Ueno M; Miida T; Nishi S; Arakawa M; Gejyo F
    Kidney Int; 2001 May; 59(5):1911-8. PubMed ID: 11318963
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MYOC gene mutations in Spanish patients with autosomal dominant primary open-angle glaucoma: a founder effect in southeast Spain.
    Campos-Mollo E; Sánchez-Sánchez F; López-Garrido MP; López-Sánchez E; López-Martínez F; Escribano J
    Mol Vis; 2007 Sep; 13():1666-73. PubMed ID: 17893668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy.
    Hagiwara M; Yamagata K; Matsunaga T; Arakawa Y; Usui J; Shimizu Y; Aita K; Nagata M; Koyama A; Zhang B; Mastunaga A; Saku K; Saito T
    Nephrol Dial Transplant; 2008 Jan; 23(1):381-4. PubMed ID: 17967799
    [No Abstract]   [Full Text] [Related]  

  • 57. Association of the apolipoprotein E gene, its promoter polymorphisms and haplotypes with depressive symptoms. The Cardiovascular Risk in Young Finns Study.
    Elovainio M; Puttonen S; Pulkki-Råback L; Kivimaki M; Viiri LE; Lehtimaki T; Karhunen P; Viikari J; Raitakari OT; Keltikangas-Jarvinen L
    Neuropsychobiology; 2008; 58(2):91-6. PubMed ID: 18843194
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Variable expression of familial dysbetalipoproteinemia in apolipoprotein E*2 (Lys146-->Gln) Allele carriers.
    de Knijff P; van den Maagdenberg AM; Boomsma DI; Stalenhoef AF; Smelt AH; Kastelein JJ; Marais AD; Frants RR; Havekes LM
    J Clin Invest; 1994 Sep; 94(3):1252-62. PubMed ID: 8083367
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interleukin-18 promoter polymorphisms and risk of late onset Alzheimer's disease.
    Yu JT; Tan L; Song JH; Sun YP; Chen W; Miao D; Tian Y
    Brain Res; 2009 Feb; 1253():169-75. PubMed ID: 19073159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A Case of Lipoprotein Glomerulopathy with apoE Chicago and apoE (Glu3Lys) Treated with Fenofibrate.
    Kodera H; Mizutani Y; Sugiyama S; Miyata T; Ehara T; Matsunaga A; Saito T
    Case Rep Nephrol Dial; 2017; 7(2):112-120. PubMed ID: 28966924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.